HCV DAA Therapy in Persons with HIV-HCV Genotype 1 Coinfection Results in High Rate of Sustained Virologic Response and Heterogeneity in Normalization of Soluble Markers of Immune Activation
| Image |  |
|---|---|
| Description | scientific article published on 15 May 2020 |
| Author/s |
author: Mark Sulkowski |
| Publication date | May 15, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |